Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia

S. Meers, D. Selleslag, H. Potier, A. Glasmacher, P. Mineur, V. Voelter*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Azacitidine access program for Belgian patients with myelodysplastic syndromes, acute myeloid leukemia or chronic myelomonocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences